Zosano Pharma

$1.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+11.11%) Today
-$0.04 (-2.86%) As of 11:10 PM UTC after-hours

Why Robinhood?

You can buy or sell Zosano Pharma and other stocks, options, and ETFs commission-free!

About ZSAN

Zosano Pharma Corporation Common Stock, also called Zosano Pharma, is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. The listed name for ZSAN is Zosano Pharma Corporation Common Stock.

CEO
Steven Lo
Employees
56
Headquarters
Fremont, California
Founded
2006
Market Cap
143.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
30.28M
High Today
$1.57
Low Today
$1.27
Open Price
$1.27
Volume
7.17M
52 Week High
$3.06
52 Week Low
$0.3275

ZSAN Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

IBMK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure